These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7510372)

  • 1. Neural mediation of the cardiovascular responses to intrathecal administration of substance P in the rat: slowing of the cardioacceleration by an adrenal opioid factor.
    Yashpal K; Henry JL
    Neuropeptides; 1993 Dec; 25(6):331-42. PubMed ID: 7510372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioacceleration provoked by intrathecal administration of vasoactive intestinal peptide (VIP): mediation by a non-central nervous system mechanism.
    Rochford J; Henry JL
    Neuropeptides; 1989; 14(4):243-52. PubMed ID: 2482950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An adrenal-mediated, naloxone-reversible increase in reaction time in the tail-flick test following intrathecal administration of substance P at the lower thoracic spinal level in the rat.
    Cridland RA; Henry JL
    Neuroscience; 1988 Jul; 26(1):243-51. PubMed ID: 2458544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P given intrathecally at the spinal T9 level increases arterial pressure and heart rate in the rat.
    Yashpal K; Gauthier S; Henry JL
    J Auton Nerv Syst; 1987 Feb; 18(2):93-103. PubMed ID: 2437174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the cardiovascular effects produced by the spinal action of substance P in the rat.
    Couture R; Hasséssian H; Gupta A
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):270-83. PubMed ID: 2452919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular responses induced by intrathecal substance P in the conscious freely moving rat.
    Hasséssian H; Couture R
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):594-602. PubMed ID: 2470997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathoadrenal mechanisms underlying cardiovascular responses to intrathecal substance P in conscious rats.
    Hasséssian H; Couture R; de Champlain J
    J Cardiovasc Pharmacol; 1990 May; 15(5):736-44. PubMed ID: 1692933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressor and tachycardic responses to intravenous substance P in anesthetized rats.
    Hancock JC; Lindsay GW
    Peptides; 1995; 16(8):1439-45. PubMed ID: 8745056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal administration of calcitonin gene-related peptide (CGRP) increases heart rate and decreases arterial pressure in the urethane anesthetized rat.
    Rochford J; Yashpal K; Henry JL
    Brain Res Bull; 1990 Dec; 25(6):809-16. PubMed ID: 1981173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate, NMDA and NMDA receptor antagonists: cardiovascular effects of intrathecal administration in the rat.
    Hong YG; Henry JL
    Brain Res; 1992 Jan; 569(1):38-45. PubMed ID: 1351773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P and GABAergic effects on adrenal and autonomic function evoked by microinjections into trigeminal subnucleus caudalis in the cat.
    Bereiter DA; Gann DS
    Brain Res; 1989 Jun; 490(2):307-19. PubMed ID: 2475206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the cardiovascular effects produced by the spinal action of two substance P analogues in the rat: evidence for a central catecholaminergic mechanism.
    Couture R; Gupta A; Kérouac R; Regoli D
    Eur J Pharmacol; 1987 Mar; 135(3):345-54. PubMed ID: 2438149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats. Implications for cardiovascular adaptation to behavioral responses.
    Unger T; Becker H; Petty M; Demmert G; Schneider B; Ganten D; Lang RE
    Circ Res; 1985 Apr; 56(4):563-75. PubMed ID: 2579749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intrathecal administration of arginine-vasopressin and substance P on blood pressure and adrenal secretion of epinephrine in rats.
    Riphagen CL; Bauce L; Veale WL; Pittman QJ
    J Auton Nerv Syst; 1986 Jun; 16(2):91-9. PubMed ID: 2424966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional peripheral and CNS hemodynamic effects of intrathecal administration of a substance P receptor agonist.
    Helke CJ; Phillips ET; O'Neill JT
    J Auton Nerv Syst; 1987 Nov; 21(1):1-7. PubMed ID: 2450116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and underlying mechanisms of human opiorphin on cardiovascular activity in anesthetized rats.
    Tian XZ; Chen Y; Bai L; Luo P; Du XJ; Chen Q; Tian XM
    Eur J Pharmacol; 2015 Feb; 749():32-8. PubMed ID: 25460028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular responses to intrathecal administration of L- and D-baclofen in the rat.
    Hong Y; Henry JL
    Eur J Pharmacol; 1991 Jan; 192(1):55-62. PubMed ID: 1645677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal administration of delta receptor agonists in the urethane anesthetized rat provokes an increase in arterial pressure via a non-opioid mechanism.
    Rochford J; Henry JL
    Brain Res; 1990 Apr; 512(2):259-68. PubMed ID: 2162234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.